01—History
Revenue History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2019–FY2025. Drag across the bars to change the range.
- $94.19B
02—Ledger
Revenue, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $94.19B | +6.0% | 10-K | |
| FY2024 | $88.82B | +4.3% | 10-K | |
| FY2023 | $85.16B | +8.2% | 10-K | |
| FY2022 | $78.74B | −4.7% | 10-K | |
| FY2021 | $82.58B | +0.6% | 10-K | |
| FY2019 | $82.06B | +0.6% | 10-K | |
| FY2018 | $81.58B | +6.7% | 10-K | |
| FY2017 | $76.45B | +9.1% | 10-K | |
| FY2016 | $70.07B | −5.7% | 10-K | |
| FY2014 | $74.33B | +4.2% | 10-K | |
| FY2013 | $71.31B | +6.1% | 10-K | |
| FY2012 | $67.22B | +9.2% | 10-K | |
| FY2011 | $61.59B | −0.5% | 10-K | |
| FY2010 | $61.90B | −2.9% | 10-K | |
| FY2008 | $63.75B | +4.3% | 10-K | |
| FY2007 | $61.09B | — | 10-K |
03—Questions
What is revenue?
Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
What is JOHNSON & JOHNSON's current revenue?
JOHNSON & JOHNSON (JNJ) annual revenue for 2025 was $94.19B, a 6.05% increase from 2024. JOHNSON & JOHNSON revenue for the quarter ending June 28, 2026 was $25.31B.
What was JOHNSON & JOHNSON's revenue in 2024?
JOHNSON & JOHNSON annual revenue for 2024 was $88.82B, a 4.30% increase from 2023.
What was JOHNSON & JOHNSON's revenue in 2023?
JOHNSON & JOHNSON annual revenue for 2023 was $85.16B, a 8.15% increase from 2022.
What is JOHNSON & JOHNSON's 4-year revenue CAGR?
JOHNSON & JOHNSON revenue grew at a compound annual growth rate (CAGR) of 3.34% from FY2021 to FY2025, going from $82.58B to $94.19B over 4 years.
- Company
- JOHNSON & JOHNSON
- Ticker
- JNJ
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations